Adial Pharmaceuticals (NASDAQ:ADIL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Adial Pharmaceuticals Stock (NASDAQ: ADIL) stock price, news, charts, stock research, profile.

Open	$1.05
Close	$1.05
Volume / Avg.	53.38K / 2.70M
Day Range	$1.04 - $1.08
52 Wk Range	0.77 - 4.30
Market Cap	$6.79M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	4.35%
Days to Cover	1.85

Recent News

EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder

Adial Pharmaceuticals has partnered with Boudicca Dx to advance the regulatory and technical strategy for its companion diagnostic test for AD0 for Alcohol Use Disorder. This collaboration is pivotal for Adial's upcoming Phase 3 trial.

Vandana Singh

EXCLUSIVE: Adial Pharmaceuticals' Last Patient Dosed in Pharmacokinetics Study of AD04 For Alcohol Use Disorder, Data Expected In Q4

Adial Pharmaceuticals announces the completion of the pharmacokinetics study dosing for AD04, their lead investigational treatment for Alcohol Use Disorder in heavy drinking patients. Topline results expected in Q4 2024 will inform Phase 3 clinical trial plans.

Vandana Singh

Gold Moves Higher; Coca-Cola Increases FY24 Forecast

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.05
Close	$1.05
Volume / Avg.	53.38K / 2.70M
Day Range	$1.04 - $1.08
52 Wk Range	0.77 - 4.30
Market Cap	$6.79M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	4.35%
Days to Cover	1.85

About Adial Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adial Pharmaceuticals (ADIL) stock?

You can purchase shares of Adial Pharmaceuticals (NASDAQ:ADIL) through any online brokerage.

View our list of the best stock brokerages

Who are Adial Pharmaceuticals (ADIL) competitors?

Other companies in Adial Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Jaguar Health (NASDAQ:JAGX) and Hepion Pharmaceuticals (NASDAQ:HEPA).

What is the forecast, or price target, for Adial Pharmaceuticals (ADIL) stock?

Adial Pharmaceuticals has a consensus price target of $6.00.

What is the current price for Adial Pharmaceuticals (ADIL)?

The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $1.0405 last updated September 24, 2024 at 3:59 PM EDT.

Does Adial Pharmaceuticals (ADIL) pay a dividend?

There are no upcoming dividends for Adial Pharmaceuticals.

When is Adial Pharmaceuticals (NASDAQ:ADIL) reporting earnings?

Adial Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Adial Pharmaceuticals (ADIL) going to split?

There is no upcoming split for Adial Pharmaceuticals.

What sector and industry does Adial Pharmaceuticals (ADIL) operate in?

Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge